Mauna Kea Technologies SA (EPA:ALMKT)

Market Cap	8.44M
Revenue (ttm)	8.42M
Net Income (ttm)	-10.40M
Shares Out	74.99M
EPS (ttm)	-0.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	590,474
Average Volume	1,604,860
Open	0.1132
Previous Close	0.1188
Day's Range	0.1124 - 0.1210
52-Week Range	0.0609 - 0.5250
Beta	1.05
RSI	47.32
Earnings Date	Oct 2, 2025

About Mauna Kea Technologies

Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 65
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMKT

Financial Performance

In 2024, Mauna Kea Technologies's revenue was 8.42 million, a decrease of -23.69% compared to the previous year's 11.03 million. Losses were -10.40 million, 179.2% more than in 2023.